Vaccination for monkeypox prevention in persons with high-risk sexual behaviours to control on-going outbreak of monkeypox virus clade 3.
Eskild Petersen(Statens Serum Institut), MPG Koopmans(Erasmus University Rotterdam), Danny Asogun(Irrua Specialist Teaching Hospital), Jean B. Nachega(Johns Hopkins University), Nathan Kapata(Ministry of Health), Tieble Traore, L Simonsen(Roskilde University), Richard Kock(University of London), Lucille Blumberg(National Center for Disease Control), Shui Shan Lee(Chinese University of Hong Kong), Alimuddin Zumla(UCL Biomedical Research Centre), Francine Ntoumi(Fondation Congolaise Pour La Recherche Médicale), Ali Abbara(National Health Service), Sofia R. Valdoleiros(Hospital de São João), Giuseppe Ippolito(Ministero della Salute), DR Lucey(Dartmouth College), Osman Dar(Chatham House), Najmul Haider(University of London), Lateefat Amao(Nigeria Centre for Disease Control), Asma Al Balushi(Sultan Qaboos University Hospital), David S.C. Hui(Chinese University of Hong Kong), Markus Maeurer(Karolinska Institutet)
Cited by 70
Related Papers
Coronaviruses — drug discovery and therapeutic options
|Nature Reviews Drug Discovery|2016|1.8k
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
|New England Journal of Medicine|2010|1.1k
Self-Reported Symptoms and Medication Side Effects Influence Adherence to Highly Active Antiretroviral Therapy in Persons With HIV Infection
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2001|470
Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa
|International Journal of Infectious Diseases|2021|437
Association between high serum total cortisol concentrations and mortality from COVID-19
|The Lancet Diabetes & Endocrinology|2020|260